News & events
Q-linea announces strong support of the TO1 warrant program as well as an extension of existing loan from large shareholder
Interim report 1 January - 31 March 2025
Strong start to the year with accelerating momentumFirst quarter: 1 January–31 March 2025Five customer contracts were signed during the...
Read more >
First ASTar® evaluation in Abu Dhabi, United Arab Emirates
Q-linea AB (publ) (OMX: QLINEA) today announces the initiation of the first clinical evaluation of ASTar at Sheikh Kalifa...
Read more >
Changed date for Interim Report
The board of Q-linea AB (publ) ("Q-linea" or the "Company") has decided to bring forward the date for the...
Read more >
Q-linea announces tender win in Italy
Q-linea AB (publ) (OMX: QLINEA) today announces the awarding of a rapid AST tender for the Naples region.Q-linea’s ASTar®...
Read more >
Additional allocation of units within the framework of recently completed issues
Q-linea AB (publ) (”Q-linea” or the “Company”) (Nasdaq Stockholm: QLINEA) announces today that Landegren Gene Technology AB’s notification to...
Read more >
Load more